FNY Investment Advisers’s Aimmune Therapeutics AIMT Stock Holding History

FNY Investment Advisers’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-900	Closed	-$31K	–	1018
2020 Q3	$31K	Buy	+900	New	+$19.2K	0.01%	274
2018 Q3	–	Sell	-660	Closed	-$17K	–	1424
2018 Q2	$17K	Buy	+660	New	+$20.2K	0.01%	385

FNY Investment Advisers's AIMT Position: Q4 2020 in Review

FNY Investment Advisers sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 900 shares — an estimated $31K sold.

FNY Investment Advisers first reported a position in AIMT in Q2 2018 and held it in 2 quarters. The position peaked at $31K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

FNY Investment Advisers reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
FNY Investment Advisers sold 900 Aimmune Therapeutics shares in Q4 2020, an estimated $31K.
FNY Investment Advisers first reported a position in Aimmune Therapeutics in Q2 2018 and held it in 2 quarters.
FNY Investment Advisers's Aimmune Therapeutics position peaked at $31K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on FNY Investment Advisers's 13F filing for Q4 2020, filed 19 Jan 2021.